Furthermore, pharmacological blocking of colony-stimulating factor 1 receptor in an early stage of AD also diminished neuroinflammation, particularly NLRP3 signaling alongside enhanced autophagy through modulation of mTOR activity [106]. Here, MTOR is linked to Alzheimer disease.